Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F LoBuglio

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|May 2, 1985
An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocytopenic purpuraR Hoffman, S Zaknoen, H H Yang, et al.
Blood|January 1, 1987
Platelet surface-bound IgG in patients with immune and nonimmune thrombocytopeniaW S Court, J M Bozeman, S J Soong, et al.
The Journal of Urology|June 1, 1987
Development and characterization of a monoclonal antibody to human embryonal carcinomaM B Khazaeli, W H Beierwaltes, G S Pitt, et al.
American Journal of Obstetrics and Gynecology|January 1, 1987
Radioimmunoscintigraphic detection of occult gestational choriocarcinomaR L Wahl, M B Khazaeli, A F LoBuglio, et al.
Pharmaceutical Research|June 1, 1990
Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patientsJ M Trang, A F LoBuglio, R H Wheeler, et al.
Journal of the National Cancer Institute|August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune responseM B Khazaeli, M N Saleh, R H Wheeler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1987
Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigenD R Shaw, M B Khazaeli, L K Sun, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 2, 2001
A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancerJ A Posey, M B Khazaeli, A DelGrosso, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administrationR M Conry, M B Khazaeli, M N Saleh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 28, 1998
Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic diseaseM N Saleh, D Y Lalisan, M W Pride, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|May 2, 1985
An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocytopenic purpuraR Hoffman, S Zaknoen, H H Yang, et al.
Blood|January 1, 1987
Platelet surface-bound IgG in patients with immune and nonimmune thrombocytopeniaW S Court, J M Bozeman, S J Soong, et al.
The Journal of Urology|June 1, 1987
Development and characterization of a monoclonal antibody to human embryonal carcinomaM B Khazaeli, W H Beierwaltes, G S Pitt, et al.
American Journal of Obstetrics and Gynecology|January 1, 1987
Radioimmunoscintigraphic detection of occult gestational choriocarcinomaR L Wahl, M B Khazaeli, A F LoBuglio, et al.
Pharmaceutical Research|June 1, 1990
Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patientsJ M Trang, A F LoBuglio, R H Wheeler, et al.
Journal of the National Cancer Institute|August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune responseM B Khazaeli, M N Saleh, R H Wheeler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1987
Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigenD R Shaw, M B Khazaeli, L K Sun, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 2, 2001
A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancerJ A Posey, M B Khazaeli, A DelGrosso, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administrationR M Conry, M B Khazaeli, M N Saleh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 28, 1998
Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic diseaseM N Saleh, D Y Lalisan, M W Pride, et al.
Pageof 17